News Sentiment

PSH0 sentiment intelligence

Sernova Biotherapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 3 relevant articles
Exchange GER Germany
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.11 Week of 19 Jun 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

66/100 classification confidence.

Company focus 3

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+40.9% over one week, +7.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Pancreas removal: FDA grants Sernova orphan tag for own-cell diabetes transplant

Market Reaction

Price moving ahead of tone

53/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 66/100 classification
One-week reaction 40.9% Price confirming higher
Trend fit Trend inactive 7.6% over four weeks
Fair value -51.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 3
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 3
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 2
MarketBeat 1

Event Lens

What the news is about

Classified themes
Market update 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-3 of 3